LYZ

protein-coding

lysozyme, the group of Lysozymes, c-type

Gene summary

This gene encodes human lysozyme, whose natural substrate is the bacterial cell wall peptidoglycan (cleaving the beta[1-4]glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine). Lysozyme is one of the antimicrobial agents found in human milk, and is also present in spleen, lung, kidney, white blood cells, plasma, saliva, and tears. The protein has antibacterial activity against a number of bacterial species. Missense mutations in this gene have been identified in heritable renal amyloidosis. [provided by RefSeq, Oct 2014]

MANE transcript

NM_000239.3

Inheritance

AD

ClinVar variants

P:5U:36B:21

Top phenotype

Amyloidosis, systemic nonneuropathic

gnomAD constraint

pLI —, LoF o/e 1.08

Max pathogenic AF

—

Genomic locus

chr12:69,348,381-69,354,234

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~5.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

familial visceral amyloidosisSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007099

Submitter: PanelApp Australia

familial visceral amyloidosisMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0007099

Submitter: Ambry Genetics

familial visceral amyloidosisSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007099

Submitter: Labcorp Genetics (formerly Invitae)

ALys amyloidosisSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019732

Submitter: Orphanet

Clinical Genomic Database (CGD)

Amyloidosis, systemic nonneuropathicAD

Manifestation: Dermatologic; Gastrointestinal; Renal

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Comments: The treatment of amyloidosis differs depending on the genetic cause (and genetic diagnosis may additionally help avoid relatively high-risk treatment regimens), and in lysozyme amyloidosis, liver and renal transplantation may be beneficial, but it is not clear that early (genetic) diagnosis would be beneficial

Refs: 8464497; 15745733; 21988333Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to LYZ variants in ClinVar

6 Conditions Cataloged
not providedTotal: 28
Amyloidosis, hereditary systemic 5Total: 26
Inborn genetic diseasesTotal: 19
Familial visceral amyloidosis, Ostertag typeTotal: 11
not specifiedTotal: 9
LYZ-related disordersTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000239.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
6
clinvar
7
missense
5
clinvar
28
clinvar
12
clinvar
1
clinvar
46
nonsense
4
clinvar
2
clinvar
6
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
3
clinvar
3
Total503620162

Highest pathogenic variant AF is 6.8408065e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 7 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000239.3RefSeqNP_000230.14MANE Select
ENST00000261267.7EnsemblENSP00000261267.24MANE Select
ENST00000548839.1EnsemblENSP00000449969.12Standard
ENST00000548839.2EnsemblENSP00000449969.12Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Salivary secretion - Homo sapiens (human)
  • Macrophage markers
  • Macrophage markers
  • Neutrophil degranulation
  • Antimicrobial peptides

Biological Process

  • retina homeostasis
  • inflammatory response
  • antimicrobial humoral response
  • cytolysis
  • killing of cells of other organism

Molecular Function

  • lysozyme activity
  • identical protein binding

Cellular Component

  • extracellular region
  • extracellular space
  • azurophil granule lumen
  • specific granule lumen
  • extracellular exosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000261267
Coding exons
4
Length
5894
Individuals with no LoFs
125672
Homozygous LoFs
0
Heterozygous LoFs
74
Defined
125746
p
0.000294
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7326583.90.7750.00000459963
Missense (PolyPhen)1020.9360.47764272
Synonymous0.01922828.10.9950.00000138284
Loss of Function-0.20187.411.084.13e-782

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000120.00012rare
Latino/Admixed American0.000400.00040rare
Ashkenazi Jewish00.0absent
East Asian0.00210.0021notable
Finnish00.0absent
European (Non-Finnish)0.000150.00014rare
South Asian0.0000650.000065rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte- macrophage system and enhance the activity of immunoagents.;
Disease
DISEASE: Amyloidosis 8 (AMYL8) [MIM:105200]: A form of hereditary generalized amyloidosis. Clinical features include extensive visceral amyloid deposits, renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash. There is no involvement of the nervous system. {ECO:0000269|PubMed:8464497}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.101

Intolerance Scores

LoFtool
0.660
RVIS EVS
0.3
RVIS percentile EVS
72.01

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.988

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.